glp-1 for binge eating Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Disorder: A Narrative Review GLP-1 Drugs and Eating Disorders:

Recent national data show that obesity prevalence among Canadian adults increased from approximately 25% pre-pandemic to 33% between 20222024

Steep and prolonged calorie deficits can force your body to break down muscle mass for energy to meet energy demands

Focus on small, frequent meals with 20-25g protein each

Once in circulation, GLP-1 exerts powerful metabolic effects: it enhances glucose-dependent insulin secretion from the pancreas, suppresses excess glucagon, and signals the hypothalamic nuclei in the brain to promote satiety

After 24 weeks treatment, there were no significant differences between the groups for the primary endpoint of change in left ventricular ejection fraction, regardless of whether the patients had comorbid diabetes or not